A Phase IB/II Multi-Cohort Study of Targeted Agents with Atezolizumab for Patients with Recurrent or Persistent Endometrial Cancer
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Alliance Foundation Trials, LLC
Start Date
February 1, 2022
End Date
December 29, 2026
Administered By
Duke Cancer Institute
Awarded By
Alliance Foundation Trials, LLC
Start Date
February 1, 2022
End Date
December 29, 2026